As I read this board it I get the feeling this is $100. stock
Then ,I look and It's not $100.00, it's 1.24..What in hells" name is causing such a disparity ..I don't know if im sitting on the toilet or a gold mine and I'm afraid to turn around and look!!..still long
It's called delusion. Every biotech investor thinks their 'pet' stock is the next big thing. They buy into the story hook line and sinker. They then start talking about 'sure thing' and 'too the moon', and 'how the rest of the world is nuts because they just can't see the value locked up in this gem'. I see it on almost every board.
Then they start planning on where they are going to hold their first millionaires party. Someone inevitably says 'maybe we should just buy our own island'.
the way you separate delusion from future winner is to ask a few questions. Is this a one trick pony? No, INO has several potential products that could justify a $billion market cap, flu, HIV, etc. Does it have proprietary technology? yes electroporation is a patented game changer, so this is not easily copied. moreover the DNA bits used in the vaccines are not something that a cheap chemical drug manufacturer could copy either. Is management good and does it have good partners? Dr. Kim is very noted in his field and there is cooperation with UPenn, which is a leading research institute in vaccines and Merck.
So why is it still cheap? Because we are at Phase 1 with most of our products. also we are trading OTC and are a cheap stock, which means many institutions are not looking at us by their own rules. the only money here is hedge funds and small traders.
While few want to hear you, I admit, I have also seen the same thing on every message board, not just bios........
Still they did have very clear success, but that is not the proof of stock expectations as all play into stock price, such as revenue, fund short selling into retail increasing money flow, all aspects of supply and demand, approval times, launch times, and so on.